Effect of caffeine citrate on diaphragmatic electrical activity in pre-term newborns

Tatiana B B Zidan1, Eduardo J Troster1, Jennifer Beck2

  • 1Departamento Materno Infantil, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.

Plos One
|April 11, 2025
PubMed

Insights

Caffeine citrate significantly boosts diaphragm electrical activity in preterm newborns, improving respiratory function. This treatment is key for managing apnea of prematurity.

Area of Science:

  • Neonatology
  • Respiratory Physiology
  • Pharmacology

Background:

  • Apnea of prematurity is a common concern in preterm infants.
  • Caffeine citrate is the established treatment, known to affect diaphragm activity.

Purpose of the Study:

  • To investigate the impact of caffeine citrate on diaphragmatic electrical activity in preterm newborns.
  • To quantify changes in inspiratory phase parameters following caffeine administration.

Main Methods:

  • Prospective, observational, longitudinal study in a tertiary neonatal ICU.
  • Electrical activity of the diaphragm measured before and after caffeine citrate loading dose.
  • Data collected from 36 preterm infants (mean GA 31 2/7 weeks).

Main Results:

  • Significant increases observed in all parameters of the inspiratory phase post-caffeine (p < 0.001).
  • Mean caffeine level was 15.7 ± 5.9 mg/dL, within the therapeutic range.
  • Enhanced diaphragmatic electrical activity was evident after administration.

Conclusions:

  • Caffeine citrate administration significantly enhances diaphragmatic electrical activity in preterm infants.
  • This supports its role in improving respiratory control for apnea of prematurity.